The formation of blood in the embryo is dependent on bone morphogenetic protein (BMP), but how BMP signaling intersects with other regulators of hematopoietic development is unclear. Using embryonic stem (ES) cells, we show that BMP4 first induces ventral-posterior (V-P) mesoderm and subsequently directs mesodermal cells toward blood fate by activating Wnt3a and upregulating Cdx and Hox genes. When BMP signaling is blocked during this latter phase, enforced expression of either Cdx1 or Cdx4 rescues hematopoietic development, thereby placing BMP4 signaling upstream of the Cdx-Hox pathway. Wnt signaling cooperates in BMP-induced hemogenesis, and the Wnt effector LEF1 mediates BMP4 activation of Cdx genes. Our data suggest that BMP signaling plays two distinct and sequential roles during blood formation, initially as an inducer of mesoderm, and later to specify blood via activation of Wnt signaling and the Cdx-Hox pathway.
INTRODUCTION
Fate-mapping studies of mouse embryogenesis show that different mesodermal populations-blood, vasculature, kidney, cardiac, and skeletal muscle-arise in an orderly manner from distinct regions of the primitive streak (PS) (Lawson et al., 1991; Tam and Beddington, 1987) . PS cells are patterned in response to gradients of embryonic morphogens, but how morphogen combinations specify distinct tissue fates remains poorly understood.
In Xenopus, formation of primitive and definitive blood requires bone morphogenetic protein (BMP) signaling (Walmsley et al., 2002) . BMPs promote blood formation by specifying mesoderm during early dorsoventral (DV) patterning. BMP induction during early gastrulation causes excess ventral-posterior (V-P) mesoderm and enhanced hematopoiesis. However, recent data document a subsequent role for BMP, showing that manipulation of the BMP pathway during mid-/late or even post-gastrulation enhances blood formation without gross morphological effects (Kumano et al., 1999; Marom et al., 2005; Schmerer and Evans, 2003) . Moreover, specific involvement of the BMP signaling transducers Smad1 and Smad5 has been recently demonstrated in zebrafish blood development (McReynolds et al., 2007) . In the mouse, BMP4 deficiency results in early lethality due to severe mesodermal defects (Winnier et al., 1995) . At later embryonic stages, BMP4 expresses in the vicinity of emerging blood cells in the murine yolk sac and human AGM (Farrington et al., 1997; Marshall et al., 2000) .
Mesodermal patterning is linked to homeobox-containing Hox genes, which confer positional identity to tissues emerging from the PS. Hox genes display an overlapping and graded expression pattern along the antero-posterior (AP) axis, and specific tissues express particular ''Hox codes'' (Favier and Dolle, 1997; Gruss and Kessel, 1991; Krumlauf, 1994) . The caudal (Cdx) family of homeobox genes conveys positional information from morphogens (e.g., Wnts, FGF, retinoids) to Hox genes during tissue formation (Lohnes, 2003) , and recent studies have demonstrated that cdx1a and cdx4 specify zebrafish embryonic blood via specific hox genes (Davidson et al., 2003; Davidson and Zon, 2006) .
Embryonic stem (ES) cells are an accessible in vitro model that can be genetically manipulated and probed with morphogens. ES cells differentiate into embryoid bodies (EBs) that consist of tissues from all three germ layers (Keller, 2005) , and form blood cells in an ordered manner corresponding to normal ontogeny (Keller et al., 1993) . The hemangioblast, the earliest hematopoietic precursor cell displaying both hematopoietic and vascular potential, was first identified in this system and later in mouse embryos (Choi et al., 1998; Huber et al., 2004) .
In this study, we use murine ES cells to explore mesoderm and hematopoietic specification during mammalian embryogenesis. We provide evidence that BMP plays a two-step role during blood specification from ES cells. Initially, BMP mediates DV patterning and induces V-P mesoderm; at a later phase, BMP promotes blood specification from preformed mesodermal cells. In dissecting this second window, we discovered that Wnt signaling cooperates with BMP to promote blood fate through activation of the Cdx-Hox genetic pathway. Moreover, the cooperative effects of BMP-Wnt on the cdx pathway are evident in zebrafish, thereby establishing evolutionary conservation of this pathway for blood development. (A) BMP4 (25 ng/ml) or Noggin (500 ng/ml) was added to EBs on day 2.25 of differentiation in SFM or SCM. Phosphorylated Smad1/5/8 expression was analyzed by western blot on day 3. Actin, loading control. (B and C) (B) EBs were differentiated for 2.5 days in SCM, SCM + BMP4, or SCM + Noggin, and RNA was harvested for quantitative PCR analysis; EBs treated as in (B) were cultured further in SCM until day 6 and assayed for CD41 expression (flow cytometry) and CFU formation (C). Data in (B) and (C) are averages of at least three independent experiments and are reported as fold change in relative gene expression normalized to b-actin (B), and % change relative to SCM alone (C). Error bars represent SEM (B) or SD (C).
RESULTS

Modulating BMP Signaling in Differentiating EBs
To modulate BMP signaling during ES cell differentiation, we supplemented EB cultures with recombinant BMP4 or the BMP antagonist Noggin (Zimmerman et al., 1996) . Phosphorylation of the BMP transducer Smad1/5/ 8 and induction of the BMP target gene Id1 (Hollnagel et al., 1999) were observed upon addition of BMP4 to serum-free differentiation medium (SFM), whereas the baseline activation seen in serum-containing differentiation medium (SCM) was inhibited by Noggin but further enhanced by supplemental BMP ( Figure 1A and see Figure S1 available online). The inhibitory effects of Noggin were dose dependent and mimicked by another BMP inhibitor (Chordin; Figure S1A ).
BMP Induces V-P Mesoderm from Murine ES Cells
To explore early effects of BMP signaling, we made EBs in SCM supplemented with BMP4 or Noggin and analyzed RNA (days 2-2.5) for gene expression by quantitative PCR. BMP4 increased expression of transcription factors characteristic of V-P mesoderm (Evx1, Mesp1, Cdx1; Dush and Martin, 1992; Huber et al., 2004; Meyer and Gruss, 1993) , while strongly suppressing anterior PS markers (Goosecoid, Cerberus, FoxA2; Belo et al., 1997; Gadue et al., 2006) ; Noggin had the opposite effect ( Figure 1B ). The panmesendodermal marker brachyury was induced by BMP4, but only partly suppressed by Noggin ( Figure 1B ), suggesting that serum factors other than BMP also induce brachyury (Gadue et al., 2006) .
Because antagonizing BMP signaling suppressed V-P mesoderm, we asked whether it also reduced hematopoiesis. Day 6 EB-derived cells robustly express CD41, the earliest hematopoietic antigen (Mikkola et al., 2003) , and form hematopoietic colonies (CFUs) when assayed in methylcellulose medium. As expected, manipulation of BMP signaling between days 0-2.5 of differentiation affected CD41 + and CFU development ( Figure 1C ).
These data are consistent with prior evidence that hematopoiesis arises principally from the posterior PS (Huber et al., 2004) . Taken together, our data show that within the first 2.5 days of EB development, BMP promotes differentiation of ES cells to brachyury-expressing V-P mesoderm with elevated hematopoietic potential (phase I; Figure 2A ), an effect that corresponds to the early role of BMP in Xenopus DV patterning (Marom et al., 2005) .
BMP Signaling Is Required during Mesoderm Specification to Hematopoietic Fate
Whereas early BMP4 addition induced brachyury expression ( Figures 1B and 2A) , supplementation after day 2.25 did not Wild-type (WT; i) and transgenic tg(hsp70:bmp2b; ii and iii) zebrafish embryo were examined for gross morphology (a), and pu.1 and gata1 expression (b and c). Transient bmp2b overexpression was induced by heat shock at 75% epiboly (8 hpf) (ii), or at 50% epiboly (5.5 hpf) (iii).
(phase II in Figure 2A ; dotted versus solid line in Figure 2B ). This suggests that, in phase II, BMP acts in a distinct manner on preformed mesodermal cells, rather than inducing additional mesodermal tissue. Consistent with this, the expression of the mesodermal markers Myogenin, Odd1, and Wnt8a was not grossly modified by BMP4 during the window of brachyury expression (until day 4), although Nkx2.5 expression was suppressed, suggesting a reduction in heart progenitors ( Figure S2A ).
To define the role of BMP during hematopoietic development in phase II, we differentiated EBs in SCM for 2.25 days and added BMP or Noggin from days 2.25-6. Addition of BMP4 enhanced, while Noggin suppressed, hematopoietic CFU and CD41 + cell formation ( Figure 2C ). In SFM, where BMP signaling was shown to be strongly suppressed ( Figure 1A and Figure S1A ), almost no hematopoietic activity could be detected ( Figure 2D ). Moreover, supplementation of BMP4 was sufficient to promote blood development under these conditions ( Figures 2B and 2D ). Taken together, these results suggest that BMP4 acts distinctly in a second phase on a subset of mesodermal cells that will undergo hematopoietic differentiation.
BMP Enhances Blood Formation during Zebrafish Embryogenesis
To explore the relevance of our findings in an accessible animal model, we overexpressed BMP during zebrafish development, where V-P mesoderm formation and patterning require BMP signaling in a dose-sensitive fashion Mullins et al., 1996) . We hypothesized that BMP induction during mid-to late gastrulation would promote mesodermal blood specification without grossly affecting DV patterning. Using a transgenic zebrafish line that expresses bmp2b under a heat shock-inducible promoter, we showed that BMP activation at midgastrulation (75% epiboly; 8 hr post-fertilization [hpf]) induced only mild ventralization (V2; reduced, but present head structures, notochord, and somites; Figure 3 , iia, and Figure S2B ) compared to embryos induced at the onset of gastrulation (50% epiboly; 5.5 hpf), which were completely ventralized (V5; absent head, notochord, and somites; Figure 3 , iiia). Consistent with our hypothesis, bmp2b induction at midgastrulation strongly expanded the posterior blood islands, as assayed by expression of the blood markers gata1 and pu.1 (Figure 3 , iib and 3iic; Figure S3 ; Davidson and Zon, 2004) . The expression of the BMP-regulated V-P mesodermal marker eve1 was enhanced by BMP, yet markers of other V-P mesodermal derivatives (e.g., cdh17; kidney) were relatively unaffected, suggesting a specific role in hemogenesis ( Together, these data suggest that mid-to late gastrulation is a critical window for BMP-induced specification of hematopoietic tissue, and that the role of BMP in blood formation from V-P mesoderm is conserved in fish and mice.
BMP4 Induces the Formation of Flk1 + Hemangioblasts
Studies in ES cells and recently in zebrafish have defined the hemangioblast as the earliest precursor of the blood lineage (Choi et al., 1998; Huber et al., 2004; Kennedy et al., 2007; Vogeli et al., 2006; Wang et al., 2004; Zambidis et al., 2005 Zambidis et al., , 2006 . In the murine EB system, the hemangioblast is detected as a Flk1 + Blast colony-forming cell (BL-CFC) emerging on days 3-3.25 (Choi et al., 1998) . We asked whether BMP signaling was required for hemangioblast formation, or for their further maturation along the blood lineage. Days 3-3.25 EBs robustly expressed Flk1 ( Figure 4A ), and hematopoietic potential segregated with the Flk1 + compartment, as determined by gene expression and CFU assays ( Figures S4A and S4B ). Flk1 + cells were also enriched for Evx1 and Mesp1, reflective of their posterior mesodermal origin, while (nonhematopoietic) Flk1
À cells were enriched in the anterior PS marker Cerberus ( Figure S4B ). To determine the role of BMP signaling in hemangioblast specification, EBs were differentiated in SCM until day 2.25, and then cultured another 24 hr in SCM or SFM supplemented with BMP4 or Noggin. At day 3.25, Flk1 + cells were scored by flow cytometry and assayed for blast colony (BL-CFC) potential (Choi et al., 1998; Kennedy et al., 1997) . Supplementation of SFM with BMP4 significantly induced the formation of Flk1 + cells, as compared to addition of Noggin (Figures 4A and 4B) , an effect also seen in SCM (data not shown). Moreover, BL-CFC and hematopoietic CFUs were only detectable from EBs cultured in the presence of BMP signaling ( Figures 4C and 4D ). These effects were even stronger when comparing equal numbers of sorted Flk1 + cells ( Figure 4E ). The data indicate that not all Flk1 + cells (C) Fifty-thousand unsorted day 3.25 EB cells generated in SFM and proteins as indicated were plated into BL-CFC assays. Data are averages of absolute numbers of blast colonies from two independent experiments. (D) CFU assays from cells generated as in (C) and then further cultured in SFM + BMP4 on gelatinized plates until day 6. (E) Flk1 + cells isolated from day 3.25 EBs generated in SFM + BMP4, SFM + Noggin, SCM + BMP4, or SCM were cultured on gelatinized plates in SFM + BMP4, and CFU assays were initiated at day 6. Data are from at least two independent experiments. Error bars represent SD (A and C-E).
(F) dnTCF blocks embryonic blood formation in the zebrafish and cannot be rescued by bmp2b. Transient transgene expression was induced at 75% epiboly ($8 hpf, ii). Wild-type (WT; i), tg(hsp70:dnTCF; ii), and tg(hsp70:dnTCF; hsp70:bmp2b; iii) zebrafish embryos were examined for gross morphology (22 hpf) (a) and gata1 expression (13.5 hpf) (b).
at this stage are hematopoietic precursors, and suggest that BMP signaling plays an essential role in the establishment of Flk1 + cells with hematopoietic potential.
Having shown that BMP is essential for the formation of Flk1 + cells with hematopoietic potential, we asked whether further blood differentiation requires sustained BMP signaling. Flk1 + cells generated in BMP4 were cultured for another 3 days in SFM with Noggin or continued BMP4 supplementation. We detected hematopoietic colonies only from Flk1 + cells continuously exposed to BMP4 ( Figure S4C and data not shown), indicating a requirement for BMP signaling during the maturation to hematopoietic progenitors. Taken together, our data suggest that BMP is required for hemangioblast specification from V-P mesoderm, as well as for further differentiation along the blood lineage.
BMP and Wnt Cooperate during
Hemangioblast Formation BMP cooperates with Wnt signaling during posterior mesoderm formation in zebrafish (Szeto and Kimelman, 2004) . In the mouse, BMP and Wnt are coexpressed in the posterior PS (Gadue et al., 2005) . Moreover, Wnt directly regulates Cdx genes (Lohnes, 2003; Pilon et al., 2006 Pilon et al., , 2007 , which are essential for embryonic blood formation in zebrafish (Davidson et al., 2003; Davidson and Zon, 2006) . We therefore hypothesized that Wnt signaling, perhaps through activation of Cdx genes, might play a role in mesodermal patterning and hematopoietic specification by BMP4. We first tested whether Wnt is essential for hemangioblast specification by adding Wnt-inhibitory proteins (DKK1, SFRP2) to BMP4-containing SFM from days 2.25-3.25, and assaying for Flk1 + cell formation, BL-CFC, and hematopoietic CFU potential. Inhibition of Wnt signaling during the window of hemangioblast specification indeed compromised BMP4-dependent hemogenesis ( Figures 4C and 4D ). Flk1
+ cells were generated also in the pres- ence of Wnt inhibitors, but at reduced levels (Figures 4A and 4B) . However, even when purified and assayed in large numbers, hematopoietic activity was strongly compromised in Flk1 + cells formed in the absence of BMP ( Figure 4E ), or in the presence of Wnt inhibitors (data not shown). A gene expression analysis performed on Flk1 + cells generated in the presence of BMP4 plus Wnt inhibitors showed suppression of hematopoietic markers, and enhancement of other mesodermal markers (Odd1, WT1; Figure S5 ). CFU inhibition was achieved by either DKK1 or SFRP2 ( Figure S6A ), whereas addition of Wnt3a failed to rescue hematopoiesis suppressed by Noggin ( Figures  4C and 4D ). This shows that during V-P mesoderm patterning to hemangioblast fate, Wnt signaling is necessary, but not sufficient, in the absence of BMP, suggesting that signaling through both morphogen pathways is required simultaneously. Interestingly, BMP4, but not Wnt supplementation, was sufficient for blood fate specification in SFM, suggesting that BMP4 may recruit Wnt to cooperate in blood formation. In support of this hypothesis, we detected enhanced expression of Wnt3a upon BMP4 addition ( Figure 5A , upper panel), a pattern not seen for Wnt8a ( Figure S2A ). Wnt3a induction occurs precisely during the developmental window (days 2-4) when genetic pathways mediating blood formation are activated. These data establish a role for the Wnt pathway during hematopoietic development from murine ES cells. We confirmed the requirement of the Wnt pathway during an equivalent stage of zebrafish embryonic blood formation using a strain of zebrafish carrying a heat shock-inducible dominantnegative TCF (hs:dnTCF; Lewis et al., 2004) . Wnt inhibition at 75% epiboly profoundly suppressed gata1 expression, an effect that could not be rescued by simultaneous bmp2b overexpression in double transgenic fish (hs:dnTCF; hs:bmp2b; Figure 4F ).
Cdx and Posterior Hox Genes Are Activated during Blood Specification Cdx and posterior Hox genes have been implicated in zebrafish embryonic hematopoiesis (Davidson et al., 2003; Davidson and Zon, 2006) . Differentiating ES cells strongly express Cdx1 and Cdx4 during the developmental window of BMP-mediated mesoderm specification to blood (days 3 to 4 of EB development; Figure 5A ). To test the effects of BMP and Wnt signaling on the Cdx-Hox pathway, we differentiated EBs for 2 days to allow the formation of mesodermal cells, then supplemented cultures with relevant morphogens or inhibitors (BMP4, Noggin, activin A, or Wnt3a), and analyzed RNA by quantitative PCR. Cdx1 and Cdx4 expression was induced by both BMP4 and Wnt3a ( Figures  5A and 5B and Figure S7 ). BMP4 and Wnt3a caused a synergistic Cdx upregulation, presumably attributable to enhanced overall Wnt levels following BMP4 treatment ( Figure 5A ; Figure S7 ). Furthermore, BMP4 and Wnt3a induced posterior, and suppressed anterior, Hox genes of the A and B clusters ( Figures 5A and 5B) , while Noggin effected the opposite (Figures 5A and 5B ). High doses of activin A also suppressed posterior Hox genes (Figure 5B) , matching our observation showing suppression of hematopoiesis by this condition (data not shown).
BMP and Wnt Regulate cdx4 Expression in the Zebrafish
To explore whether the upstream regulation of the Cdx-Hox pathway by BMP-Wnt is conserved between fish and mouse, we studied the effects of conditional bmp2b overexpression on cdx gene expression in zebrafish embryos. Like their mammalian counterparts, zebrafish cdx genes are expressed in successive waves preceding the onset of scl expression (Davidson et al., 2003; Figures S3 and S8) . cdx4 mutants display severe defects in embryonic blood formation, while cdx1a morphants display a milder phenotype . Conditional activation of bmp2b during midgastrulation resulted in a widened expression domain of cdx4 in the region of developing blood precursor cells ( Figure 5C ). This preceded the upregulation of the hematopoietic markers pu.1 and gata1 that express at a later stage of development ( Figure S3 ; Davidson and Zon, 2004) . Conversely, cdx4 expression was severely reduced following Wnt inhibition by heat shock-inducible dnTCF ( Figure S6D ), consistent with the altered hematopoietic phenotype observed for this condition ( Figure 4F ). These data suggest an evolutionarily conserved role for BMP and Wnt signaling during cdx gene regulation.
Wnt Signaling Mediates BMP-Dependent Cdx Gene Activation
We hypothesized that Wnt signaling might be an intermediate step between BMP4 and activation of the Cdx-Hox pathway in blood development. To address this question, we performed chromatin immunoprecipitation (ChIP) on day 3 EB-derived cells treated with either BMP4 or Noggin, and assayed the association of the Wnt effector LEF1 with Cdx regulatory regions. As a positive control, we used a known LEF1-responsive fragment in the regulatory region of the brachyury gene ( Figure 6A ). It has been shown that Wnt3a signaling and LEF1 are required for the maintenance, but not initiation, of brachyury expression during mouse embryogenesis (Galceran et al., 2001 ). We found a modest but reproducible association of LEF1 with a proximal Cdx1 promoter fragment, which was modulated in the presence of BMP signaling ( Figure 6A ). No LEF1 binding was detected at a distal fragment of the Cdx1 promoter or in regulatory regions of Cdx4 ( Figure 6A and data not shown). We could not detect association of phosphorylated forms of the BMP-specific transcription factors Smad1/5/8 with Cdx regulatory regions, suggesting that the BMP effect on Cdx genes is indirect (data not shown).
To corroborate these results, we generated luciferase reporter gene constructs containing a minimal 0.7 kb Cdx1 promoter fragment, which has been shown in vivo to reflect the endogenous expression pattern of the Cdx1 gene (Lickert and Kemler, 2002) . This promoter fragment was sufficient to confer activation of the luciferase reporter upon addition of BMP4 or Wnt3a (Figure 6B) . Addition of the Wnt inhibitor SFRP2 markedly decreased the response of the Cdx1 promoter to BMP4 and reduced its basal activity, while treatment with Noggin had no effect on the promoter activation by Wnt3a or on basal activity levels ( Figure 6B ; Figure S6B ). Moreover, point mutations within LEF1 binding sites of the Cdx1 promoter inhibited its basal activity and abrogated its response to BMP4 or Wnt3a ( Figure 6C ), further demonstrating that BMP4 activates the Cdx1 promoter via LEF1 and the Wnt pathway.
Conditional Expression of Cdx-Hox Genes Bypasses Morphogens
To determine whether Cdx-Hox genes mediate BMP/Wnt-mediated blood specification, we asked whether enforced expression of Cdx1 or Cdx4 might rescue blood formation when BMP signaling is blocked. We used ES cells with conditionally inducible Cdx4 (iCdx4; Davidson et al., 2003; Wang et al., 2005) , or Cdx1 (iCdx1; S.M.-F. and I.H.J., unpublished data). Inducible ES cells were differentiated as EBs in SCM until day 2.25 and then transferred to SFM or SCM supplemented with Noggin, which inhibits hematopoietic development. Expression of Cdx1 or Cdx4 from days 2.25-6 rescued hematopoietic CFU formation, bypassing the BMP4 requirement during this phase ( Figure 7A ). Cdx1 had a stronger effect, fully rescuing CFU formation in all compartments (erythroid, myeloid, and GEMM), while Cdx4 showed a slight deficiency in the rescue of erythroid CFUs. These data indicate that activation of either Cdx1 or Cdx4 is sufficient to establish hematopoietic fate in the absence of BMP signaling. Induced expression of Cdx genes did not rescue the hematopoietic defect of EBs exposed to Noggin from the onset of differentiation (day 0; Figure 7A ), consistent with a phase II-specific rescue effect by the Cdx-Hox pathway in blood formation.
In the zebrafish, overexpression of hoxa9a partially rescues blood formation in cdx mutants (Davidson et al., 2003; Davidson and Zon, 2006) . To explore this effect in murine ES cells, we generated inducible Hoxa9 ES cells (iHoxa9). Induction was confirmed by protein and gene expression ( Figures S9A and S9B) . During days 2.25-6 of EB development, Hoxa9 induction enhanced the formation of myeloid colonies ( Figure S9C ), and activation when BMP signaling was blocked partially rescued hematopoiesis ( Figure 7A and Figure S9C ). The limited rescue may reflect the fact that additional Hox genes (which Cdx1 and Cdx4 induce) are required for robust blood formation. Consistent with this, suppression of single hox genes in zebrafish does not phenocopy the strong hematopoietic defects observed in cdx mutants (Davidson et al., 2003; L.I.Z. and A.J.D., unpublished data) .
Wnt Signaling Mediates Cdx Crossregulation
We asked whether Cdx genes are strictly downstream of BMP/ Wnt, or may rescue blood development by inducing morphogen expression. We exposed days 2-2.25 EBs from iCdx1 and iCdx4 ES cells to doxycycline, and then collected samples after 4 hr, 8 hr, and 16 hr for quantitative gene expression analysis. Conditional Cdx gene expression failed to induce BMP4 or Wnt8a, but did stimulate Wnt3a expression ( Figure 7B ). Furthermore, Cdx1 and Cdx4 positively crossregulated each other ( Figure 7B ). Cdx1 was a more potent inducer of Cdx4 (Figure 7B ), possibly explaining its stronger effect in functional assays ( Figure 7A ; S.M-F., C.L., I.H.J., S.S., J. Shea, Y. Wang, M. Philitas, and G.Q.D., unpublished data). Because Cdx1 upregulated Wnt3a, we asked whether Cdx crossregulation was mediated by Wnt. Indeed, simultaneous addition of Wnt inhibitors reduced the activation of Cdx4 by Cdx1 ( Figure 7C ). Matching these molecular results, functional experiments showed slightly lower numbers of hematopoietic CFUs in Cdx1 rescue experiments performed in the presence of SFRP2 and DKK1, as compared to cultures without Wnt inhibitors (data not shown).
DISCUSSION
BMP4 enhances hematopoietic differentiation from ES cells (Chadwick et al., 2003; Li et al., 2001 ), but the genetic pathways linking BMP action to blood fate specification have not been defined. In this study, we have uncovered sequential roles for BMP in the induction of V-P mesoderm and the specification of hematopoietic fate. We discovered a previously unsuspected coordination between BMP4 and Wnt3a signaling in embryonic hematopoiesis and linked these morphogens directly to Cdx and Hox genes. Moreover, we have demonstrated conservation of these pathways in zebrafish. Together, our data provide a mechanistic framework that links embryonic morphogens and a central genetic pathway for blood development.
Our work builds upon prior studies that demonstrated the action of BMP4 on blood development. Using Scl +/CD4 knockin ES cells, Park et al. showed that BMP4 induces Flk1 + and Scl + cells under serum-free conditions (Park et al., 2004) . More recently, ectopic expression of the BMP transducer Smad1 was shown to expand hemangioblast populations derived from murine ES cells, suggesting a role for BMP signaling during patterning and/or survival and proliferation of these cells (Zafonte et al., 2007) . At later stages, BMP signaling activates hematopoietic transcription factors such as Gata2 and Runx1, promoting the maturation along the blood lineage (Lugus et al., 2007; Pimanda et al., 2007) . Consistent with data from Xenopus embryogenesis, we have identified distinct phases where BMP is required during hematopoietic development from mouse ES cells and have validated these results in another model vertebrate, the zebrafish. During the first 2 days of EB development, BMP promotes the formation of V-P mesoderm. Subsequently, BMP is essential for the formation of Flk1 + hemangioblasts and their maturation into hematopoietic progenitors. In support of this model, in vivo studies in mouse embryos have found that ablation of BMP4 from the onset of development causes gross mesoderm defects, presumably because DV patterning is disrupted (Winnier et al., 1995) . BMP4 is expressed later in defined anatomical sites of blood formation (yolk sac mesoderm and AGM; Farrington et al., 1997; Marshall et al., 2000) . Conditional Smad4 inactivation in Flk1 + cells significantly compromised murine blood formation (Park et al., 2006) , further implicating the BMP/TGF-b/activin pathway in murine blood specification.
During embryonic development, positional information is translated from morphogen pathways to Hox genes, which by virtue of their restricted expression domains confer positional identity along the AP axis. In zebrafish, cdx genes have been identified as essential regulators of embryonic blood formation, controlling the ''hox code'' responsible for hematopoietic identity (Davidson et al., 2003; Davidson and Zon, 2006) . Cdx-deficient zebrafish embryos lack embryonic blood and display aberrant hox gene expression (Davidson et al., 2003; Davidson and Zon, 2006) . In contrast to zebrafish, Cdx1 and Cdx4 single and double null mutant mice manifest no gross hematopoietic defects (van Nes et al., 2006) , perhaps due to functional redundancy among the three mammalian Cdx genes (Cdx1, 2, and 4) . However, we have observed reduced hematopoiesis in Cdx1 null and Cdx4 null murine ES cells differentiated in vitro, suggesting that compensatory responses occur within the developing mouse embryo that are absent in vitro (Y. Wang and G.Q.D., unpublished data) . A null mutant of all three murine Cdx genes has not been reported and is technically challenging because Cdx2 null embryos die early due to trophectodermal defects. Although there are differences in the degree of severity of cdx mutants in the zebrafish and the mouse, we show that BMP and Wnt signaling play a conserved role in promoting Cdx activation and blood development in both species.
Hemangioblasts have been isolated from the posterior PS of mouse embryos (Huber et al., 2004) , a region of high BMP4, Wnt3a, and Cdx expression (Gadue et al., 2005; Ikeya and Takada, 2001) . Wnt regulates Cdx genes during mouse (Ikeya and Takada, 2001 ) and zebrafish embryogenesis (Shimizu et al., 2005) , and Wnt3a mouse mutants and wnt3a/wnt8 morphant zebrafish embryos display caudal phenotypes reminiscent of cdx1/ cdx4 mutants. Recently, Wnt3a has been shown to be a direct regulator of murine Cdx1 and Cdx4 (Pilon et al., 2006 (Pilon et al., , 2007 . We have shown that BMP4 induces Wnt signaling, which is required for Cdx1 and Cdx4 activation and for hemangioblast specification, and that overexpression of either Cdx1 or Cdx4 in the absence of BMP4 signaling can functionally rescue blood development from mouse ES cells. We also detected Wnt-mediated crossregulation between Cdx1 and Cdx4. Cdx1 autoregulation has been described, and previous reports have identified physical interactions and documented synergy between Cdx1 and LEF1 (Beland et al., 2004) . Emerging data from other laboratories indicate that the regulation of downstream Hox genes by Cdx genes is also often associated with Wnt responsiveness, supporting the finding that Wnt signaling plays a major role in regulating the Cdx-Hox pathway (Robb Krumlauf, personal communication) .
Although we propose a linear BMP-Wnt-Cdx-Hox pathway, our data also imply that BMP has non-Wnt-dependent modes of promoting blood formation, as Wnt3a was not itself sufficient to rescue blood formation in the absence of BMP signaling. Enforced Cdx expression did rescue hematopoietic differentiation, but it is possible that high levels of Cdx gene expression in our conditional system may override a requirement for BMP-dependent cofactors.
Recent data in the adult zebrafish have established that BMP and Wnt regulate cdx4, and that both can stimulate the regeneration of the hematopoietic system in an adult zebrafish injury model (T.V.B. and L.I.Z., unpublished data). Given the evolutionary conservation of these pathways from fish to mice, we anticipate that principles gleaned from studies in the fish can be exploited to direct the differentiation of human ES cells into blood. Furthermore, as shown by recent studies implicating Cdx genes in leukemia, embryonic studies may provide valuable insights into pathways activated in human disease (Bansal et al., 2006; Scholl et al., 2007) .
EXPERIMENTAL PROCEDURES ES Cell Culture and Differentiation
Murine ES cells were cultured and differentiated as described (Kyba et al., 2002) . Serum-containing differentiation medium (SCM) contained 15% fetal calf serum (Stem Cell Technologies). For SFM, fetal calf serum was substituted with 15% knockout serum replacement medium (GIBCO), and 100 ng/ml hFlt3L, 100 ng/ml hSCF, 80 ng/ml mVEGF, and 50 ng/ml basic FGF (all from Peprotech) were added. Proteins (R&D Systems) were used as follows (unless otherwise indicated): 25 ng/ml (SFM), 50 ng/ml (SCM) BMP4; 250 ng/ml (SFM), 500 ng/ml (SCM) Noggin; 50 ng/ml Wnt3a; 200 ng/ml DKK1; 1 mg/ml SFRP2; 100 ng/ml activin A; and 3.5 mg/ml Chordin. For 2D culture assays, day 3 EBs were dissociated to single cells by 0.25% trypsin (Invitrogen) and plated at a density of 1 3 10 5 cells/cm 2 in tissue culture dishes precoated with 1% gelatin. After 3 days of 2D culture, cells were harvested by trypsin and plated into CFU assays.
Inducible Hoxa9 ES Cells Hoxa9 cDNA (Krivtsov et al., 2006) was subcloned into plox and electroporated with pSALK-Cre into 4 3 10 6 AinV15 ES cells (ATCC; Kyba et al., 2002 were isolated with magnetic anti-PE microbeads (Miltenyi Biotech). Purity was routinely >90%.
Colony Assays
Hematopoietic progenitor colony assays were performed as described (Perlingeiro et al., 2003) , and CFUs were scored based on gross morphology: erythroid (E), myeloid (M), granulocyte-macrophage (GM), erythroid-granulocyte-monocyte-macrophage-megakaryocytic multilineage (GEMM). Blast cell colonies (BL-CFC) were assayed as described (Choi et al., 1998) .
Gene Expression Analysis
Total RNA was isolated using RNA-Stat 60 (TelTest) and treated with DNase I (Ambion), and cDNAs were prepared according to the manufacturer's instruction (Invitrogen). Real-time PCR was performed with SYBR green reagent kits (Stratagene) on an MX3000P Stratagene PCR machine. Primer sequences were used as published (Ernst et al., 2004) , or as listed in Table S2A .
Western Blot Phosphorylated Smad1/5/8 was detected using a rabbit antibody (Chemicon), Hoxa9 expression was detected with rabbit antisera (Upstate), and actin was detected via a mouse antibody (BD Transduction Laboratories). Secondary antibodies used were horseradish peroxidase coupled anti-rabbit or antimouse antisera (GE Healthcare).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described, using day 3.1 EBs preincubated with BMP4 (50 ng/ml) or Noggin (250 ng/ml) in SFM (Orlando et al., 1997; Weinmann and Farnham, 2002) . Ten micrograms anti-LEF1 antibody (H-70, Santa Cruz Biotechnology) was used per sample, and immunoprecipitated DNA was analyzed by real-time PCR. Relative enrichments represent abundance of precipitated material compared with input control, followed by normalization to a fragment within the GAPDH gene. Primer sequences are listed in the Table S1B .
Luciferase Reporter Gene Assays A 0.7 kb Cdx1 promoter sequence (Lickert and Kemler, 2002) amplified from genomic DNA using primers LUCI1 was cloned into the XhoI site of pGL3 basic (Promega), generating the pGL3-X1-0.7 kb construct. The mapped LEF/TCF binding sites at positions À113 and À82 (Lickert et al., 2000) were mutated using the Stratagene QuikChange site-directed mutagenesis kit. Sequences are listed in Table S1C . Constructs were verified by sequencing. Day 2.1 EB-derived cells were transferred to 24-well plates and transfected using Lipofectamine 2000 (Invitrogen). For each sample, transfections were carried out in triplicate, using 800 ng of reporter plasmid together with 8 ng pRLSV40 Renilla luciferase control vector (Promega). Luciferase expression was assessed 24 hr later using the Dual-Luciferase Reporter Assay System (Promega).
Zebrafish Embryo Experiments
Zebrafish were maintained and bred as described (Solnica-Krezel et al., 1994) . Wild-type Ab and Tg(hsp70:bmp2b) or Tg(hsp70:dnTCF) were used. To induce bmp2b or dnTCF expression, the embryos were incubated in a water bath at 36 C for 15 min. Embryos were scored for gross morphology, fixed overnight at 4 C in 4% paraformaldehyde, and processed by whole-mount in situ hybridization (Davidson et al., 2003) . Digoxygenin-labeled antisense RNA probes were synthesized using a DIG RNA labeling kit (SP6/T7; Roche). For gene expression analysis, five to eight wild-type Ab embryos were collected at the designated stage. Primer sequences are listed in Table S2D .
Statistical Analysis
Student's t test was used for statistical analysis. P values were indicated in Table S1 and in the figures as follows: *p = 0.05-0.01, **p = 0.01-0.001, and ***p < 0.001. Error bars show standard error (SEM) or standard deviation (SD). Results regarding statistical significance (p value) are listed in Table S1 .
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Supplemental Data include nine figures and two tables and can be found with this article online at http://www.cellstemcell.com/cgi/content/full/2/1/ 72/DC1/.
